Karen L. Zaderej
CIK 1530968 · CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$48.56M
Companies
3
Total Filings
75
Lifetime Open-Market Net
-$2.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 5 of 8
75 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-18 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2020-02-20 | AXGN | Mixed | +24,564 | -$79.7K | EDGAR |
| 2020-01-17 | AXGN | Mixed | +29,888 | -$175.3K | EDGAR |
| 2019-12-20 | AXGN | Grant (A) | +6,250 | $0 | EDGAR |
| 2019-11-27 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-12 | AXGN | Buy (P) | +75,000 | $1.01M | EDGAR |
| 2019-07-02 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +37,829 | $0 | EDGAR |
| 2019-05-31 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-31 | AXGN | Exer (M) | +18,056 | $4.9K | EDGAR |
| 2019-04-03 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +14,248 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.